1. 265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort. (9th November 2020) Authors: Deville, Jean-Laurent; Ravaud, Alain; Maruzzo, Marco; Gourdin, Theodore; Maio, Michele; Dirix, Luc; Wang, XiaoZhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Jeorg; Chennoufi, Sarah; Gulley, James Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort. (9th November 2020) Authors: Deville, Jean-Laurent; Ravaud, Alain; Maruzzo, Marco; Gourdin, Theodore; Maio, Michele; Dirix, Luc; Wang, XiaoZhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Jeorg; Chennoufi, Sarah; Gulley, James Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib. (February 2022) Authors: Rebuzzi, Sara Elena; Cerbone, Luigi; Signori, Alessio; Santoni, Matteo; Murianni, Veronica; De Giorgi, Ugo; Procopio, Giuseppe; Porta, Camillo; Milella, Michele; Basso, Umberto; Massari, Francesco; Maruzzo, Marco; Iacovelli, Roberto; Battelli, Nicola; Carmisciano, Luca; Banna, Giuseppe Luigi; But... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Can serial FCH-PET/CT scans predict the response to treatments in castrate resistant prostate cancer?. Issue 1 (2018) Authors: Evangelista, Laura; Maruzzo, Marco; Basso, Umberto; Cervino, Anna Rita Journal: Journal of diagnostic imaging in therapy Issue: Volume 5:Issue 1(2018) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical management of aggressive fibromatosis/desmoid tumour. (October 2014) Authors: Maruzzo, Marco; Benson, Charlotte; Miah, Aisha; Judson, Ian Journal: Expert opinion on orphan drugs Issue: Volume 2:Number 10(2014:Oct.) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020–Sep 2020; Sep 2020–May 2021) in the Veneto Oncology Network: The ROVID study. (May 2022) Authors: Dieci, Maria V.; Azzarello, Giuseppe; Zagonel, Vittorina; Bassan, Franco; Gori, Stefania; Aprile, Giuseppe; Chiarion-Sileni, Vanna; Lonardi, Sara; Oliani, Cristina; Zaninelli, Marta; Chiari, Rita; Favaretto, Adolfo; Pavan, Alberto; Di Liso, Elisabetta; Mioranza, Eleonora; Baldoni, Alessandra; Ber... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience. Issue 2 (March 2021) Authors: Pierantoni, Francesco; Basso, Umberto; Maruzzo, Marco; Lamberti, Evelina; Bimbatti, Davide; Tierno, Giuseppina; Bergo, Eleonora; Brunello, Antonella; Zagonel, Vittorina Journal: Journal of geriatric oncology Issue: Volume 12:Issue 2(2021) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication. Issue 1 (4th January 2023) Authors: Buti, Sebastiano; Basso, Umberto; Giannarelli, Diana; De Giorgi, Ugo; Maruzzo, Marco; Iacovelli, Roberto; Galli, Luca; Porta, Camillo; Carrozza, Francesco; Procopio, Giuseppe; Fonarini, Giuseppe; Lo Re, Giovanni; Santoni, Matteo; Sabbatini, Roberto; Cusmai, Antonio; Zucali, Paolo Andrea; Aschele,... Journal: Journal of immunotherapy Issue: Volume 46:Issue 1(2023) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®). Issue 3 (June 2023) Authors: Caminiti, Caterina; Bryce, Jane; Riva, Silvia; Ng, Diane; Diodati, Francesca; Iezzi, Elisa; Sparavigna, Lucia; Novello, Silvia; Porta, Camillo; Del Mastro, Lucia; Procopio, Giuseppe; Cinieri, Saverio; Falzetta, Amalia; Calabrò, Fabio; Lorusso, Vito; Cogoni, Alessio Aligi; Tortora, Giampaolo; Maru... Journal: Tumori Issue: Volume 109:Issue 3(2023) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case report. Issue 2 (27th August 2020) Authors: Dionese, Michele; Pierantoni, Francesco; Maruzzo, Marco; Bimbatti, Davide; Deppieri, Filippo M.; Maran, Michela; Gardiman, Marina P.; Basso, Umberto Journal: Anti-cancer drugs Issue: Volume 32:Issue 2(2021) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗